El-Husseini Amr A, Foda Mohamed A, Osman Yasser M, Sobh Mohamed A
Mansoura Urology & Nephrology Center, Mansoura University, Mansoura, Egypt.
Pediatr Transplant. 2006 May;10(3):288-93. doi: 10.1111/j.1399-3046.2005.00455.x.
To study the characteristics and the predictors of survival observed in our pediatric live-donor renal transplant recipients with an allograft that functioned for more than 10 yr.
One hundred fifteen children underwent renal transplantation between 1976 and 1995. Of these, 30 had functioning allografts for more than 10 yr (range, 11-18). The patients included 18 males and 12 females, with a mean age at transplantation of 13 yr (range, 5-18). Characteristics of the patients, data on graft survival, and determinants of outcome were obtained by reviewing all medical charts.
At most recent follow-up (January 2005), the mean daily dose of azathioprine was 1.2 mg/kg (range, 1-2) and that of prednisone was 0.16 mg/kg (range, 0.1-0.2). Mean creatinine clearance was 72 mL/min per 1.73 m(2) (range, 45-112). Acute rejection occurred in 14 (47%) patients. Seven patients had one episode, five had two episodes, and two had three episodes of acute rejection. Three patients (10%) developed malignancy. A substantial proportion of patients (44%) were short, with a height standard deviation score (SDS) less than -1.88, which is below the third percentile for age and gender. One quarter of the patients, more commonly the females, were obese. Other complications included osteoporosis in 16 (53%) patients, avascular bone necrosis in four (13%), post-transplantation diabetes mellitus in three (10%), and hypertension in 18 (60%). Twelve (40%) patients were married and 27% had children post-transplantation. The independent determinants of long-term graft survival were acute rejection and post-transplant hypertension.
Despite good renal function, long-term pediatric renal transplant survivors are at risk of significant morbidity. The determinants of long-term graft survival are acute rejection and post-transplant hypertension.
研究在我们中心接受活体供肾肾移植且移植肾存活超过10年的儿科受者的生存特征及预测因素。
1976年至1995年间,115名儿童接受了肾移植。其中,30名受者的移植肾存活超过10年(范围为11至18年)。患者包括18名男性和12名女性,移植时的平均年龄为13岁(范围为5至18岁)。通过查阅所有病历获取患者特征、移植肾存活数据及预后决定因素。
在最近一次随访(2005年1月)时,硫唑嘌呤的平均每日剂量为1.2mg/kg(范围为1至2mg/kg),泼尼松的平均每日剂量为0.16mg/kg(范围为0.1至0.2mg/kg)。平均肌酐清除率为每1.73m² 72mL/min(范围为45至112mL/min)。14名(47%)患者发生了急性排斥反应。7名患者发生1次急性排斥反应,5名患者发生2次,2名患者发生3次急性排斥反应。3名患者(10%)发生了恶性肿瘤。相当一部分患者(44%)身材矮小,身高标准差评分(SDS)低于 -1.88,低于年龄和性别的第三百分位数。四分之一的患者肥胖,女性更为常见。其他并发症包括16名(53%)患者发生骨质疏松,4名(13%)患者发生缺血性骨坏死,3名(10%)患者发生移植后糖尿病,18名(60%)患者发生高血压。12名(40%)患者已婚,27%的患者移植后生育。长期移植肾存活的独立决定因素是急性排斥反应和移植后高血压。
尽管肾功能良好,但长期存活的儿科肾移植受者仍有发生严重并发症的风险。长期移植肾存活的决定因素是急性排斥反应和移植后高血压。